CYP2B6
protein-codingcytochrome P450 family 2 subfamily B member 6, the group of Cytochrome P450 family 2
Gene summary
This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008]
- CYP2B
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~27.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
Clinical Genomic Database (CGD)
Manifestation: General
Intervention: Pharmacogenomic
Rationale: It has been suggested that CYP2B6 genotype should be considered in efavirenz treatment
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CYP2B6 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_000767.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 10 | 10 | ||||
| missense | 82 | 6 | 88 | |||
| nonsense | 2 | 2 | ||||
| start loss | 0 | |||||
| frameshift | 2 | 2 | ||||
| splice donor/acceptor (+/-2bp) | 1 | 1 | ||||
| Total | 0 | 0 | 85 | 16 | 2 | 103 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_000758.1 | 9 | MANE Select | |
| Ensembl | ENSP00000324648.2 | 9 | MANE Select | |
| Ensembl | ENSP00000470582.1 | 5 | Standard | |
| Ensembl | ENSP00000470582.1 | 5 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Artemisinin and Derivatives Pathway, Pharmacokinetics
- Retinol metabolism - Homo sapiens (human)
- Metabolism of xenobiotics by cytochrome P450 - Homo sapiens (human)
- Drug metabolism - cytochrome P450 - Homo sapiens (human)
- Arachidonic acid metabolism - Homo sapiens (human)
Biological Process
- organic acid metabolic process
- xenobiotic metabolic process
- steroid metabolic process
- drug metabolic process
- epoxygenase P450 pathway
Molecular Function
- monooxygenase activity
- iron ion binding
- arachidonic acid epoxygenase activity
- steroid hydroxylase activity
- oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
Cellular Component
- cytoplasm
- endoplasmic reticulum membrane
- organelle membrane
- intracellular membrane-bounded organelle
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000324071
- Coding exons
- 9
- Length
- 27100
- Individuals with no LoFs
- 125354
- Homozygous LoFs
- 5
- Heterozygous LoFs
- 389
- Defined
- 125748
- p
- 0.00157
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.976 | 332 | 286 | 1.16 | 0.0000177 | 3221 |
| Missense (PolyPhen) | 100 | 93.172 | 1.0733 | 1180 | ||
| Synonymous | -1.50 | 131 | 111 | 1.18 | 0.00000679 | 984 |
| Loss of Function | 0.737 | 17 | 20.6 | 0.825 | 0.00000135 | 217 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.024 | 0.013 | notable |
| Latino/Admixed American | 0.0015 | 0.0013 | notable |
| Ashkenazi Jewish | 0.0058 | 0.0058 | notable |
| East Asian | 0.00027 | 0.00027 | rare |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.00051 | 0.00047 | rare |
| South Asian | 0.00056 | 0.00052 | rare |
| Other | 0.0023 | 0.0018 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. Acts as a 1,4-cineole 2-exo-monooxygenase. {ECO:0000269|PubMed:11695850, ECO:0000269|PubMed:20061448, ECO:0000269|PubMed:21875942, ECO:0000269|PubMed:22909231}.;
Intolerance Scores
- LoFtool
- 0.888
- RVIS EVS
- 2.36
- RVIS percentile EVS
- 98.44
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.303
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |